Literature DB >> 3306823

Patterns of autoimmunity to nucleoproteins in patients with systemic lupus erythematosus.

J A Hardin, J E Craft.   

Abstract

The ANAs described above can be accounted for on the basis of an immune response to just three nucleoprotein structures--the nucleosome, the U1 snRNP, and the Ro particle. When these nucleoproteins are looked at in turn, the following picture emerges. The nucleosome is identified by both anti-histone and anti-DNA antibodies. Anti-histone H1 and anti-histone H2B antibodies predominate and tend to occur together. They, as well as the anti-DNA antibodies with which they appear to be linked, recognize external features of the intact nucleosome. The U1 snRNP is recognized by both anti-U1 RNP and anti-Sm antibodies. Most so-called anti-U1 RNP antisera actually contain several linked sets of different antibodies that are directed against various polypeptides (68K, A, and C) found on the U1 snRNP. Anti-Sm antibodies are linked to the occurrence of anti-U1 RNP antibodies. The Ro particle is recognized by both anti-La and anti-Ro antibodies, and almost all sera that contain anti-La antibodies also contain anti-Ro antibodies. Thus, it appears that these three nucleoprotein particles become direct focal points for autoimmune responses in SLE. It is difficult to explain such focused responses on the basis of a general defect in immune regulation or spontaneous B-lymphocyte hyperactivity. Rather it appears that these nucleoproteins themselves are directly involved in determining which B-lymphocyte clones become activated. Thus, the simplest rationalization for the patterns with which these autoantibodies occur is to invoke the possibility that the particles themselves are directly triggering autoimmune responses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3306823

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  9 in total

Review 1.  Autoantigens in systemic autoimmunity: critical partner in pathogenesis.

Authors:  A Rosen; L Casciola-Rosen
Journal:  J Intern Med       Date:  2009-06       Impact factor: 8.989

Review 2.  Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors.

Authors:  Sean R Christensen; Mark J Shlomchik
Journal:  Semin Immunol       Date:  2007-02-02       Impact factor: 11.130

Review 3.  Autoantigens as Partners in Initiation and Propagation of Autoimmune Rheumatic Diseases.

Authors:  Antony Rosen; Livia Casciola-Rosen
Journal:  Annu Rev Immunol       Date:  2016-02-22       Impact factor: 28.527

Review 4.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

5.  Haemodialysis as a model for studying endogenous plasma DNA: oligonucleosome-like structure and clearance.

Authors:  P Rumore; B Muralidhar; M Lin; C Lai; C R Steinman
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

6.  Apoptotic cell blebs: repositories of autoantigens and contributors to immune context.

Authors:  Tomeka Suber; Antony Rosen
Journal:  Arthritis Rheum       Date:  2009-08

Review 7.  The role of B cells in lupus pathogenesis.

Authors:  Emil Nashi; YingHua Wang; Betty Diamond
Journal:  Int J Biochem Cell Biol       Date:  2009-10-20       Impact factor: 5.085

Review 8.  Complement and systemic lupus erythematosus.

Authors:  Mark J Walport
Journal:  Arthritis Res       Date:  2002-05-09

9.  Breakdown of B cell tolerance in a mouse model of systemic lupus erythematosus.

Authors:  J H Roark; C L Kuntz; K A Nguyen; A J Caton; J Erikson
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.